New York State Common Retirement Fund
LYEL icon

New York State Common Retirement Fund’s Lyell Immunopharma LYEL Stock Holding History

New York State Common Retirement Fund’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.6K Buy
+4,100
New +$74.2K ﹤0.01% 2945
2025
Q2 		– Sell
-2,563
Closed -$27.6K – 3278
2025
Q1 		$27.6K Hold
2,563
– – ﹤0.01% 2925
2024
Q4 		$32.8K Hold
2,563
– – ﹤0.01% 2958
2024
Q3 		$70.7K Hold
2,563
– – ﹤0.01% 2741
2024
Q2 		$74.3K Buy
2,563
+61
+2% +$2.9K ﹤0.01% 2983
2024
Q1 		$112K Sell
2,502
-62
-2% -$2.65K ﹤0.01% 2694
2023
Q4 		$99.5K Sell
2,564
-17
-0.7% -$612 ﹤0.01% 2749
2023
Q3 		$75.9K Buy
2,581
+26
+1% +$1.24K ﹤0.01% 2857
2023
Q2 		$163K Sell
2,555
-1,961
-43% -$109K ﹤0.01% 2594
2023
Q1 		$213K Sell
4,516
-1,371
-23% -$73.3K ﹤0.01% 2556
2022
Q4 		$409K Sell
5,887
-3
-0.1% -$298 ﹤0.01% 2413
2022
Q3 		$863K Buy
5,890
+403
+7% +$54.6K ﹤0.01% 2048
2022
Q2 		$716K Buy
5,487
+42
+0.8% +$4.29K ﹤0.01% 2182
2022
Q1 		$550K Buy
5,445
+4,750
+683% +$576K ﹤0.01% 2359
2021
Q4 		$108K Buy
695
+200
+40% +$44.6K ﹤0.01% 3056
2021
Q3 		$147K Buy
+495
New +$148K ﹤0.01% 3019

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

New York State Common Retirement Fund's LYEL Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Lyell Immunopharma (LYEL) in Q2 2026: 4,100 shares worth $57.6K. The stake represents ﹤0.01% of the portfolio and ranks #2945 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in LYEL as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in LYEL in Q3 2021 and has held it in 16 quarters since. The position peaked at $863K in Q3 2022. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • New York State Common Retirement Fund held 4,100 shares of Lyell Immunopharma worth $57.6K as of Q2 2026.
  • Lyell Immunopharma was a new New York State Common Retirement Fund position in Q2 2026.
  • Lyell Immunopharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2945 holding.
  • New York State Common Retirement Fund first reported a position in Lyell Immunopharma in Q3 2021 and has held it in 16 quarters since.
  • New York State Common Retirement Fund's Lyell Immunopharma position peaked at $863K in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.